Navigation Links
Pharmasset Reports Fiscal Second Quarter 2009 Financial Results
Date:5/11/2009

he Phase 2b with Roche in second half of 2009;
  • Report phase 1 antiviral data with PSI-7851 in second half of 2009;
  • Report further data from INFORM-1 trial in fourth quarter of 2009.

  • About Pharmasset

    Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has initiated a Phase 2b clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial.

    Pegasys(R) and Copegus(R) are registered trademarks of Roche.

        Contact
        Richard E. T. Smith, Ph.D.
        VP, Investor Relations and Corporate Communications
        richard.smith@pharmasset.com
        Office: +1 (609) 613-4181
    

    Forward-Looking Statements

    Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any
    '/>"/>

    SOURCE Pharmasset, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
    2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
    3. Pharmasset Accesses up to $30 Million of Working Capital
    4. Pharmasset to Present at Three Investor Conferences in November 2007
    5. Pharmasset Appoints Michael Rogers as Chief Development Officer
    6. Pharmasset Reports Fiscal Year End 2007 Financial Results
    7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
    8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
    9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
    10. Pharmasset Appoints Herbert J. Conrad as a Director
    11. Pharmasset Receives $10 Million of Working Capital
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/21/2014)... July 21, 2014 Lawrence ... Investment Board (WIB) and Las Positas College (LPC) ... technical education and hands-on training for veterans, officials ... Program at Las Positas is designed to ... for engineering technician careers, and establishes a pipeline ...
    (Date:7/21/2014)... Arts and Sciences has received a major grant ... Mathew M. Maye, associate professor of chemistry, has ... National Science Foundation (NSF). The award supports his ... results of which may impact gas storage, heterogeneous ... Maye,s approach is novel, in that he is ...
    (Date:7/21/2014)... , July 21, 2014 ... & USA Cancer Biomaker ... Forecasts ResearchMoz presents this most up-to-date ...   to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, ... Pipeline Analysis. GLOBAL & ...
    (Date:7/20/2014)... July 20, 2014 NSG Precision ... glass optics, and spectrophotometer calibration standards ... NSG has released many products that have transformed ... has been their solid-state calibration standards. , NSG’s ... since their release in 2008. NSG started ...
    Breaking Biology Technology:Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 2How NSG Precision Cells Spectrophotometer Calibration Standards Makes NIR Work Easier 3
    ... 29 CPC of America, Inc.,(OTC Bulletin Board: ... Advisors, LLC, the investment banking subsidiary of FTI ... As CPC of America,s financial advisor, FTI ... of interest from third parties seeking to,pursue a ...
    ... individuals of all ages who,have reached beyond the ... ATLANTA, Sept. 29 UCB today announced the ... which this year awarded a,total of $300,000 in ... scholarship program was established to recognize individuals,of all ...
    ... 29 NOMAD Bioscience GmbH,Munich, Germany ... developing,plant-made biomaterials and biopharmaceuticals that address ... series of high-value products such as,nanopatterned ... and,enzymes for important markets including biofuels, ...
    Cached Biology Technology:CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities 2UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 2UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 3UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 4UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 5Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals 2
    (Date:7/21/2014)... Could stuffing yourself full of high-fat foods cause you ... study from Florida State University neuroscientists says so, and ... our diets could impact a whole range of human ... impact of obesity. , "This opens up a lot ... post-doctoral researcher Nicolas Thiebaud, who led the study examining ...
    (Date:7/21/2014)... Growers of annual bedding plant seedlings or ... with a large stem diameter and high root ... damage during shipping and transplant. To achieve these ... rely on supplemental lighting from high-pressure sodium lamps ... light-emitting diodes (LEDs) can give greenhouse growers other ...
    (Date:7/21/2014)... cannot regulate their body temperature, so their cells are ... slightly colder temperatures, some biological processes in the cell ... the cells, delicate chemical balance out of whack. Yet, ... Now researchers from the University of Rochester and the ... do that. , "The production of proteins is ...
    Breaking Biology News(10 mins):New research links bad diet to loss of smell 2LEDs shine in bedding plant production study 2When temperatures get cold, newly-discovered process helps fruit flies cope 2
    ... simple, chemical materials model may lead to a better ... according to a Penn State researcher. "Cells are interesting ... the cytoplasm, and while it is thought to be ... how this organization is achieved," said Christine Keating, associate ...
    ... A group of Texas-based researchers provided answers for ... a very short window by the U.S. Environmental Protection ... The EPA issued a final ruling on Dec. ... of these gases by large confined animal feeding operations ...
    ... diseases like cancer typically destroy nasty malignant cells, ... advances in synthetic biology, researchers are designing molecules ... healthy cells alone. "We basically design molecules that ... analysis of the cellular state before delivering the ...
    Cached Biology News:Artificial cells, simple model for complex structure 2Artificial cells, simple model for complex structure 3Texas researchers provide emissions data for livestock industry 2Texas researchers provide emissions data for livestock industry 3Texas researchers provide emissions data for livestock industry 4Engineers create intelligent molecules that seek-and-destroy diseased cells 2Engineers create intelligent molecules that seek-and-destroy diseased cells 3
    ... offers the most comprehensive, cost-effective solution ... have incorporated unprecedented quality into both ... includes proven detection chemistries and antibodies ... TechMate protocol. It also includes our ...
    Human Cell Line Slides...
    Mouse Cell Line Slides...
    Request Info...
    Biology Products: